149 related articles for article (PubMed ID: 26293348)
1. Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer.
Hooks SB; Murph MM
Future Med Chem; 2015 Aug; 7(12):1483-9. PubMed ID: 26293348
[TBL] [Abstract][Full Text] [Related]
2. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
Hooks SB; Callihan P; Altman MK; Hurst JH; Ali MW; Murph MM
Mol Cancer; 2010 Nov; 9():289. PubMed ID: 21044322
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells.
Cacan E
J Chemother; 2017 Jun; 29(3):173-178. PubMed ID: 28102109
[TBL] [Abstract][Full Text] [Related]
4. Regulator of G protein signaling 10: Structure, expression and functions in cellular physiology and diseases.
Almutairi F; Lee JK; Rada B
Cell Signal; 2020 Nov; 75():109765. PubMed ID: 32882407
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells.
Altman MK; Alshamrani AA; Jia W; Nguyen HT; Fambrough JM; Tran SK; Patel MB; Hoseinzadeh P; Beedle AM; Murph MM
Cancer Lett; 2015 Dec; 369(1):175-83. PubMed ID: 26319900
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.
Cacan E; Ali MW; Boyd NH; Hooks SB; Greer SF
PLoS One; 2014; 9(1):e87455. PubMed ID: 24475290
[TBL] [Abstract][Full Text] [Related]
7. A broad analysis in clinical and in vitro models on regulator of G-protein signalling 10 regulation that is associated with ovarian cancer progression and chemoresistance.
Kucuk B; Kibar B; Cacan E
Cell Biochem Funct; 2021 Apr; 39(3):413-422. PubMed ID: 33354811
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells.
Ali MW; Cacan E; Liu Y; Pierce JY; Creasman WT; Murph MM; Govindarajan R; Eblen ST; Greer SF; Hooks SB
PLoS One; 2013; 8(3):e60185. PubMed ID: 23533674
[TBL] [Abstract][Full Text] [Related]
9. RGS10 suppression by DNA methylation is associated with low survival rates in colorectal carcinoma.
Caldiran FY; Cacan E
Pathol Res Pract; 2022 Aug; 236():154007. PubMed ID: 35810565
[TBL] [Abstract][Full Text] [Related]
10. Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins.
Alqinyah M; Hooks SB
Cell Signal; 2018 Jan; 42():77-87. PubMed ID: 29042285
[TBL] [Abstract][Full Text] [Related]
11. RGS10 Regulates the Expression of Cyclooxygenase-2 and Tumor Necrosis Factor Alpha through a G Protein-Independent Mechanism.
Alqinyah M; Almutairi F; Wendimu MY; Hooks SB
Mol Pharmacol; 2018 Oct; 94(4):1103-1113. PubMed ID: 30049816
[TBL] [Abstract][Full Text] [Related]
12. Functional Assessment of Cancer-Linked Mutations in Sensitive Regions of Regulators of G Protein Signaling Predicted by Three-Dimensional Missense Tolerance Ratio Analysis.
Montañez-Miranda C; Perszyk RE; Harbin NH; Okalova J; Ramineni S; Traynelis SF; Hepler JR
Mol Pharmacol; 2023 Jan; 103(1):21-37. PubMed ID: 36384958
[TBL] [Abstract][Full Text] [Related]
13. How regulators of G protein signaling achieve selective regulation.
Xie GX; Palmer PP
J Mol Biol; 2007 Feb; 366(2):349-65. PubMed ID: 17173929
[TBL] [Abstract][Full Text] [Related]
14. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
Hurst JH; Henkel PA; Brown AL; Hooks SB
Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
[TBL] [Abstract][Full Text] [Related]
15. Shipping Drug Resistance: Extracellular Vesicles in Ovarian Cancer.
Strandmann EPV; Müller R
Trends Mol Med; 2016 Sep; 22(9):741-743. PubMed ID: 27474394
[TBL] [Abstract][Full Text] [Related]
16. Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven Inflammation.
Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Maddalena F; Condelli V; Landriscina M; Esposito F
Adv Protein Chem Struct Biol; 2017; 108():163-198. PubMed ID: 28427560
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms that determine selective RGS protein regulation of G protein-coupled receptor signaling.
Neitzel KL; Hepler JR
Semin Cell Dev Biol; 2006 Jun; 17(3):383-9. PubMed ID: 16647283
[TBL] [Abstract][Full Text] [Related]
18. Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
Hu Y; Zheng M; Wang S; Gao L; Gou R; Liu O; Dong H; Li X; Lin B
Genomics; 2021 Jul; 113(4):2134-2144. PubMed ID: 33845140
[TBL] [Abstract][Full Text] [Related]
19. Regulation of RGS3 and RGS10 palmitoylation by GnRH.
Castro-Fernández C; Janovick JA; Brothers SP; Fisher RA; Ji TH; Conn PM
Endocrinology; 2002 Apr; 143(4):1310-7. PubMed ID: 11897687
[TBL] [Abstract][Full Text] [Related]
20. Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.
Lee JK; Bou Dagher J
AAPS J; 2016 May; 18(3):545-9. PubMed ID: 26902301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
